ANI Pharmaceuticals | ANIP - EPS Earnings Per Share


ANI Pharmaceuticals reported $2.33 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 1.58 1.70 May/08 2026
FY2025Q4 Dec/2025 2.33 1.97 1.63 Feb/27 2026
FY2025Q3 Sep/2025 2.04 1.71 1.34 Nov/07 2025
FY2025Q2 Jun/2025 1.80 1.43 1.02 Aug/08 2025
FY2025Q1 Mar/2025 1.70 1.12 1.21 May/09 2025




Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
ANI Pharmaceuticals USD 2.33 0.29 Dec/2025
Assertio Holdings USD -0.03 0.01 Sep/2024
Aurora Cannabis CAD -1 0.73 Sep/2025
Canopy Growth CAD -0.08 0.14 Sep/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Emergent BioSolutions USD -0.77 0.29 Dec/2023
Heron Therapeutics USD -0.02 0.02 Dec/2025
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
Knight Therapeutics CAD 0.03 0.06 Sep/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Novartis USD 2.02 0.04 Sep/2025
Omeros USD -1.12 0.37 Jun/2024
Perrigo USD 0.77 0.03 Dec/2025
Sun Pharmaceuticals INR 12.8 0.2 Dec/2025
Teva Pharmaceutical Industries USD 2.98 0.43 Dec/2025